Abeona therapeutics appoints edward carr as chief financial officer

New york and cleveland, aug. 10, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced the appointment of edward carr as chief financial officer and principal financial officer, effective immediately. mr. carr had served as abeona's chief accounting officer since january 2019.

ABEO Ratings Summary

ABEO Quant Ranking